Test Price
2,800 AED✅ Home Collection Available
MMAA Gene Methylmalonic Aciduria, CblA Type – Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين MMAA لحمض الميثيل مالونيك البولي من النوع CblA – اختبار الحمض النووي بتقنية NGS في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary / ملخص تنفيذي
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139). Premium Logistics: Paid Hospital‑Grade Home Collection (8 AM–11 PM) with VIP Mobile Phlebotomy and ISO‑certified cold‑chain transport. Clinical Guidance: Telephonic post‑test clinical interpretation and a mandatory genetic counselling session before testing. Insurance: Direct Billing Verification & pre‑authorization via WhatsApp at +971 54 548 8731.
يوفر فحص جين MMAA في الإمارات تشخيصاً دقيقاً لحمض الميثيل مالونيك البولي من النوع CblA وفق معايير هيئة الصحة بدبي لعام 2026. نضمن دقة تشخيصية بنسبة 99.9% عبر معالجة مخبرية معتمدة من ISO، مع خدمة سحب عينات منزلية فاخرة ونقل بارد وفق المعايير الدولية. يتضمن الفحص استشارة وراثية وإرشاداً طبياً هاتفياً بعد النتائج.
Overview
The MMAA Gene Methylmalonic Aciduria CblA Type NGS Test is a highly advanced genetic analysis that screens the entire MMAA gene for pathogenic variants causing CblA‑type Methylmalonic Aciduria, a treatable inborn error of metabolism. In the UAE, this test is performed under strict DHA‑mandated protocols, helping physicians, clinical geneticists, and primary care doctors confirm a diagnosis, guide vitamin B12 (cobalamin) therapy, and enable early intervention.
| Feature | Our Test (NGS DNA Sequencing) | Closest Alternative (Biochemical Metabolite Screen) |
|---|---|---|
| Diagnostic Precision | 99.9% sensitivity – detects single nucleotide variants, indels, and copy number changes | Limited – measures methylmalonic acid levels only; may miss mild or intermittent cases |
| Methodology | Next‑Generation Sequencing (NGS) with Sanger confirmation | Gas Chromatography‑Mass Spectrometry (GC‑MS) of urine organic acids |
| Turnaround Time | 3 to 4 Weeks (standard) | 1 to 2 Weeks |
Physician Insight & Safety Protocol
“As a DHA‑licensed physician, I recognise the anxiety a suspected metabolic disorder brings. The MMAA gene test provides definitive molecular confirmation, enabling personalised cobalamin therapy and accurate genetic counselling for your family. However, every result must be interpreted alongside the full clinical picture, including metabolic parameters and symptom history.”
— Dr. PRABHAKAR REDDY, General Physician, DHA License No. 61713011
Medication Warning
Do not discontinue prescribed vitamin B12 injections, special formulas, or any other medication without consulting your treating physician. This test is diagnostic; treatment adjustments require medical oversight.
Safety Exclusion Criteria & ER Red Flags
- Exclusion: Active febrile illness requiring hospitalisation; coagulopathy or anticoagulant therapy that precludes safe venipuncture (whole blood sample) – use FTA card or extracted DNA after consultation.
- Red Flags: Sudden onset of vomiting, lethargy, seizures, or breathing difficulty in a suspected metabolic patient – seek emergency medical care immediately. Do not wait for genetic test results.
- Pre‑Test Requirement: A genetic counselling session to draw a pedigree chart of family members affected with Methylmalonic Aciduria CblA type is mandatory. The test requires a completed clinical history form.
- Specimen Logistics: Whole blood, extracted DNA, or one drop of blood on an FTA card accepted. Samples must be collected by a certified phlebotomist and transported in ISO‑certified cold‑chain conditions.
Patient FAQ & Clinical Guidance
1. What exactly does the MMAA gene test detect?
Our MMAA gene test sequences DNA to find CblA-type Methylmalonic Aciduria mutations, guiding precise treatment.
This next‑generation sequencing test analyses all coding regions of the MMAA gene, identifying pathogenic variants that cause vitamin B12‑responsive methylmalonic aciduria, CblA type. It confirms the diagnosis at a molecular level, helps differentiate it from other forms of methylmalonic acidemia, and supports family screening and reproductive planning.
يقوم اختبار جين MMAA بتسلسل الحمض النووي الكامل للجين لاكتشاف الطفرات المسببة لنوع CblA من حمض الميثيل مالونيك البولي، مما يمكّن الأطباء من تأكيد التشخيص وتوجيه العلاج بفيتامين B12 بدقة.
2. Who should consider this genetic test in the UAE?
Individuals with unexplained metabolic acidosis, developmental delay, or a family history of B12‑responsive methylmalonic aciduria should consider testing.
The test is indicated for symptomatic patients (neonates through adults) presenting with lethargy, failure to thrive, recurrent vomiting, or neurological signs. Asymptomatic siblings of confirmed cases, couples planning pregnancy where both are carriers, and individuals with abnormal newborn screening results also benefit. A referral from a metabolic specialist or clinical geneticist is strongly recommended.
يُنصح بالفحص لكل من يعاني من أعراض حمضية استقلابية غير مفسرة، أو تأخر في النمو، أو تاريخ عائلي للإصابة بحمض الميثيل مالونيك البولي المستجيب لفيتامين B12. كما يُستخدم للكشف عن الحاملين للمرض وللتخطيط العائلي.
3. How long does it take to receive results, and how are they delivered?
Results are typically ready within 3 to 4 weeks and are delivered via a secure online portal with DHA‑mandated confidentiality.
After your sample arrives at our ISO‑accredited lab, extraction, NGS, bioinformatics analysis, and clinical interpretation require 21–28 calendar days. You will receive a comprehensive report detailing the genetic variant, its clinical significance, and treatment implications. A telephonic post‑test consultation with a genetic counsellor or referring physician is included to explain the findings and answer any concerns.
تظهر النتائج خلال 3 إلى 4 أسابيع، ويتم تسليمها عبر بوابة إلكترونية آمنة مع الالتزام بسرية هيئة الصحة بدبي. يشمل ذلك تقريراً طبياً مفصلاً واستشارة هاتفية لشرح النتائج والتوجيه العلاجي.
This complies with UAE Federal Decree‑Law No. 41 of 2024 (Art. 87) on medical liability, the CDS Law 2026 governing genomic testing in minors, and the UAE Personal Data Protection Law (PDPL) for health data privacy.
All laboratory processes are performed under ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139). Facility License: 9834453. For insurance billing, WhatsApp +971 54 548 8731.
DHA‑Assigned ICD‑10‑CM Codes: E71.111 (Methylmalonic acidemia, vitamin B12‑responsive, CblA type), Z14.01 (Asymptomatic genetic carrier), Z13.228 (Encounter for screening for other metabolic disorders). LOINC: 81642-5 – MMAA gene full mutation analysis.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians